Collectively, these findings provide substantial evidence supporting the significant role of FBXO9-mediated ATP6V1A ubiquitination (which hinders V-ATPase assembly) in suppressing Wnt/β-catenin signaling and EMT in lung cancer cells. Here, ATP6V1A is linked to lung carcinoma.